Cargando…
Dynamic changes in the regulatory T-cell heterogeneity and function by murine IL-2 mutein
The therapeutic expansion of Foxp3(+) regulatory T cells (Tregs) shows promise for treating autoimmune and inflammatory disorders. Yet, how this treatment affects the heterogeneity and function of Tregs is not clear. Using single-cell RNA-seq analysis, we characterized 31,908 Tregs from the mice tre...
Autores principales: | Lu, Daniel R, Wu, Hao, Driver, Ian, Ingersoll, Sarah, Sohn, Sue, Wang, Songli, Li, Chi-Ming, Phee, Hyewon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156283/ https://www.ncbi.nlm.nih.gov/pubmed/32269069 http://dx.doi.org/10.26508/lsa.201900520 |
Ejemplares similares
-
Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response in vivo
por: Ma, Shining, et al.
Publicado: (2023) -
Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins
por: Ghelani, Aazam, et al.
Publicado: (2020) -
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease
por: Peterson, Laurence B., et al.
Publicado: (2018) -
MuteinDB: the mutein database linking substrates, products and enzymatic reactions directly with genetic variants of enzymes
por: Braun, Andreas, et al.
Publicado: (2012) -
Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy
por: Moorman, Cody D., et al.
Publicado: (2021)